Tick and flea treatment, Bravecto, receives FDA approval

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, announced the U.S. Food and Drug Administration's approval of BRAVECTO(R) (fluralaner topical solution) for both cats and dogs, a topical treatment for fleas and ticks effective for up to 12 weeks following a single dose. "The approval of a second BRAVECTO ["]